Clinical Trials List
2026-11-01 - 2030-10-30
Phase II/III
Not yet recruiting3
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- Ching-Chan Lin 無
- Chao-Hsiang Chang 無
- Su-Peng Yeh 無
- Yi-Huei Chang 無
- Hsi-Chin Wu 無
- Yu-De Wang 無
- 蔡禮賢 無
- Po-Jen Hsiao 無
- Chi-Shun Lien 無
- Chi-Rei Yang 無
- Po-Fan Hsieh 無
- Che-Hung Lin 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Kai-Jie Yu 無
- 張杰茵 無
- Yung-Chia Kao 無
- Yung-Chang Lin 無
- I-hung Shao 無
- 沈鼎文 無
- 吳俊德_ 無
- PO-HUNG LIN 無
- 余紹銘 無
- Hong-Cheng Gan 無
- 黃文冠 無
- See-Tong Pang 無
- 張境夫 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- JHE-CYUAN GUO 無
- Yeong-Shiau Pu 無
- FU-JEN HSUEH 無
- Po-Ting Yeh 無
- - - 無
- PO-MING CHOW 無
- CHUNG-HSIN CHEN 無
- JIAN-HUA HONG 無
- - - 無
- 闕士傑 無
- 吳書丞 無
- 莊建淮 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
630 participants
